Universal, ready-to-use immunotherapy detects and destroys endometrial cancer in preclinical tests
by Linda Wang, University of California, Los Angeles edited by Gaby Clark, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source Microscopy image of uterine papillary serous carcinoma, an aggressive subtype of endometrial cancer. Credit: Neda Moatamed/Sanaz Memarzadeh Lab Endometrial cancer is the most common gynecologic cancer in the United States and is one of […]
